tetracthib
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 23, 2005 (NCT00197028)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tetanus toxinImmunity, active
tetX immunity, active
- Bordetella pertussisImmunity, active
Bordetella pertussis immunity, active
- Haemophilus influenzaeImmunity, active
Haemophilus influenzae immunity, active
- Diphtheria toxinImmunity, active
Diphtheria toxin immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tetracthib
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00289185 | Phase 2 | Sep 27, 2006 | GlaxoSmithKline |
| NCT00197028 | Phase 2 | Aug 23, 2005 | GlaxoSmithKline |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 2 | 2 | 1 | 2005 |
1 organizations
Page 1 / 1